SHANDA SCHROEDER: Open Payments
NPI 1952973190 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 14 payments from 9 companies in 2025. Trend: 2023 $81 · 2024 $164 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $75 |
| Biogen, Inc. | 3 | $50 |
| Becton, Dickinson and Company | 1 | $38 |
| Astellas Pharma US Inc | 2 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: MYFEMBREE, ZURZUVAE, BD Onclarity, Veozah, Exparel, ABRYSVO, GARDASIL 9, Lynkuet.
Industry payments across KS — which companies pay providers there.
